Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,700
Closed -$74K 6004
2020
Q1
$74K Buy
1,700
+800
+89% +$48.5K ﹤0.01% 4984
2019
Q4
$70K Hold
900
﹤0.01% 5633
2019
Q3
$71K Buy
900
+600
+200% +$48.1K ﹤0.01% 5722
2019
Q2
$26K Sell
300
-1,500
-83% -$125K ﹤0.01% 6344
2019
Q1
$156K Buy
+1,800
New +$136K ﹤0.01% 5013
2018
Q4
Sell
-100
Closed -$7K 7178
2018
Q3
$7K Buy
+100
New +$6.84K ﹤0.01% 6729
2017
Q2
Sell
-1,000
Closed -$52K 6818
2017
Q1
$52K Buy
1,000
+400
+67% +$22.7K ﹤0.01% 5312
2016
Q4
$34K Buy
+600
New +$34.6K ﹤0.01% 5370
2016
Q1
Sell
-4,000
Closed -$264K 6326
2015
Q4
$264K Buy
+4,000
New +$285K ﹤0.01% 3689
2015
Q3
Sell
-200
Closed -$12K 6962
2015
Q2
$12K Hold
200
﹤0.01% 6003
2015
Q1
$13K Sell
200
-400
-67% -$24.5K ﹤0.01% 6077
2014
Q4
$34K Sell
600
-4,000
-87% -$213K ﹤0.01% 5994
2014
Q3
$221K Buy
4,600
+600
+15% +$30.9K ﹤0.01% 4663
2014
Q2
$212K Buy
4,000
+2,700
+208% +$148K ﹤0.01% 4765
2014
Q1
$73K Buy
1,300
+300
+30% +$17.2K ﹤0.01% 5691
2013
Q4
$56K Hold
1,000
﹤0.01% 6100
2013
Q3
$46K Buy
+1,000
New +$45.6K ﹤0.01% 6101

Other funds holding MNRO

Barclays's MNRO Position: Q1 2026 in Review

Barclays reduced its Monro (MNRO) stake by 23% in Q1 2026, selling an estimated $793K and leaving 133,414 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Barclays first reported a position in MNRO in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.13M in Q4 2019. 184 funds tracked by Wall St. Rank hold MNRO as of Q1 2026.

  • Barclays held 133,414 shares of Monro worth $2.14M as of Q1 2026.
  • Barclays sold 40,821 Monro shares in Q1 2026, an estimated $793K.
  • Monro made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2318 holding.
  • Barclays first reported a position in Monro in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Monro position peaked at $8.13M in Q4 2019.
  • 184 funds tracked by Wall St. Rank held Monro as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.